Dmitry Balyasny’s Organogenesis Holdings ORGO Stock Holding History

Dmitry Balyasny’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-261,915	Closed	-$1.36M	–	3351
2025 Q4	$1.36M	Buy	+261,915	New	+$1.27M	﹤0.01%	2053
2025 Q3	–	Sell	-28,473	Closed	-$104K	–	3325
2025 Q2	$104K	Buy	+28,473	New	+$106K	﹤0.01%	2683
2021 Q4	–	Sell	-888,464	Closed	-$12.7M	–	2506
2021 Q3	$12.7M	Buy	+888,464	New	+$13.8M	0.05%	489

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Dmitry Balyasny's ORGO Position: Q1 2026 in Review

Dmitry Balyasny sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 261,915 shares — an estimated $1.36M sold.

Dmitry Balyasny first reported a position in ORGO in Q3 2021 and held it in 3 quarters. The position peaked at $12.7M in Q3 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

Dmitry Balyasny reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
Dmitry Balyasny sold 261,915 Organogenesis Holdings shares in Q1 2026, an estimated $1.36M.
Dmitry Balyasny first reported a position in Organogenesis Holdings in Q3 2021 and held it in 3 quarters.
Dmitry Balyasny's Organogenesis Holdings position peaked at $12.7M in Q3 2021.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.